IRVINE, Calif. & MUNICH--(BUSINESS WIRE)--JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, today announced that cardiovascular medical device industry veteran Stefan Schreck, Ph.D. has been named the Company’s new chief technology officer, effective immediately.
Dr. Schreck is a prolific inventor with more than 80 US patents and patent applications and brings to JenaValve more than 30 years of technology innovation and engineering leadership.
Help employers find you! Check out all the jobs and post your resume.
